Home › Funds › NIA IMPACT ADVISORS, LLC › IBRX

NIA IMPACT ADVISORS, LLC position in IBRX

IMMUNITYBIO INC · Health Care

NIA IMPACT ADVISORS, LLC reported holding 235,907 shares of IBRX (IMMUNITYBIO INC) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 0.96% of its reported portfolio and ranking #43 among its reported holdings. NIA IMPACT ADVISORS, LLC has disclosed IBRX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)235.91K sh
Reported value held$2.23M
Portfolio Weight0.96%
First reportedQ1 2026
Last changeReduce
Updated2026-11-04

Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR

How NIA IMPACT ADVISORS, LLC's IBRX position evolved

NIA IMPACT ADVISORS, LLC first disclosed a stake in IBRX in Q1 2026 at 268,797 shares (US$2.1M). The position peaked in Q2 2026 at 270,167 shares, worth US$2.4M. Across 3 filings, NIA IMPACT ADVISORS, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 235,907 shares valued at US$2.2M — a reduction of -34,260 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 268.80K $2.06M New
Q2 2026 270.17K $2.37M Add
Q3 2026 235.91K $2.23M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBRX and 13F data

IBRX (IMMUNITYBIO INC) is a Health Care company. 68 other funds we track also report a position in IBRX — the largest reported positions include GREAT POINT PARTNERS LLC (US$26.3M), VESTOR CAPITAL, LLC (US$12.1M), Sound Capital Solutions LLC (US$9.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBRX

All IBRX fund holders →

FAQ

How long has NIA IMPACT ADVISORS, LLC held IBRX?

NIA IMPACT ADVISORS, LLC has disclosed IBRX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is NIA IMPACT ADVISORS, LLC's current position in IBRX?

As of Q3 2026, NIA IMPACT ADVISORS, LLC holds 235.91K shares of IBRX (IMMUNITYBIO INC), valued at $2.23M, representing 0.96% of its reported portfolio and ranking #43.

Has NIA IMPACT ADVISORS, LLC been buying or selling IBRX?

In the latest 13F filing (Q3 2026), NIA IMPACT ADVISORS, LLC reduced its position in IBRX. The position peaked in Q2 2026 at 270.17K shares.

Which other funds hold IBRX?

Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, VESTOR CAPITAL, LLC, Sound Capital Solutions LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.